220 related articles for article (PubMed ID: 22095175)
1. PDT in squamous cell carcinoma of the skin.
Zwiebel S; Baron E
G Ital Dermatol Venereol; 2011 Dec; 146(6):431-44. PubMed ID: 22095175
[TBL] [Abstract][Full Text] [Related]
2. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
3. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.
Morton CA; Szeimies RM; Sidoroff A; Braathen LR
J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594
[TBL] [Abstract][Full Text] [Related]
4. Spotlighting the role of photodynamic therapy in cutaneous malignancy: an update and expansion.
Ross K; Cherpelis B; Lien M; Fenske N
Dermatol Surg; 2013 Dec; 39(12):1733-44. PubMed ID: 24118243
[TBL] [Abstract][Full Text] [Related]
5. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
Morton CA
J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
[TBL] [Abstract][Full Text] [Related]
7. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory photodynamic therapy using low irradiance inorganic light-emitting diodes for the treatment of non-melanoma skin cancer: an open study.
Ibbotson SH; Ferguson J
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):235-9. PubMed ID: 22971187
[TBL] [Abstract][Full Text] [Related]
9. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
[TBL] [Abstract][Full Text] [Related]
10. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre.
Moseley H; Ibbotson S; Woods J; Brancaleon L; Lesar A; Goodman C; Ferguson J
Lasers Surg Med; 2006 Jun; 38(5):403-16. PubMed ID: 16788933
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
[TBL] [Abstract][Full Text] [Related]
12. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
13. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
14. Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience.
Wang XL; Wang HW; Guo MX; Xu SZ
Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):127-33. PubMed ID: 19356643
[TBL] [Abstract][Full Text] [Related]
15. A synthesis of the world's guidelines on photodynamic therapy for non-melanoma skin cancer.
Morton CA
G Ital Dermatol Venereol; 2018 Dec; 153(6):783-792. PubMed ID: 29417799
[TBL] [Abstract][Full Text] [Related]
16. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy.
Moseley H; Allen JW; Ibbotson S; Lesar A; McNeill A; Camacho-Lopez MA; Samuel ID; Sibbett W; Ferguson J
Br J Dermatol; 2006 Apr; 154(4):747-50. PubMed ID: 16536822
[TBL] [Abstract][Full Text] [Related]
18. Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).
Sidoroff A; Thaler P
Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):24-32. PubMed ID: 20230990
[TBL] [Abstract][Full Text] [Related]
19. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
20. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.
Gayl Schweitzer V
Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
